Navigation Links
Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
Date:2/20/2008

Year-end 2007 long-term follow-up data continues to be positive

BETHESDA, Md., Feb. 20 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) ("NWBT" or the "Company") today announced the most recent long-term follow-up data, as of year-end 2007, on disease progression and overall survival in patients taking part in its Phase I and Phase I/II clinical trials for newly diagnosed patients with Glioblastoma multiforme ("GBM"), the most aggressive form of brain cancer. The additional data covers the period from April 2007 through year-end 2007. During this time, none of the patients experienced disease progression (recurrence) and only one patient died (at 36.4 months). Thus, the data show that in the 19 clinical trial patients receiving DCVax(R)-Brain in addition to Standard of Care, both the median overall survival and the median time to disease progression (recurrence) are more than twice as long as in patients receiving the Standard of Care for GBM. Dr. Linda Liau, Associate Professor of Neurosurgery and Director of the Malignant Brain Tumor Program at the UCLA School of Medicine ("UCLA"), served as the Principal Investigator for the trial.

Since 2005, the Standard of Care for patients with GBM is surgery followed by a combination of radiation and daily Temodar(R) chemotherapy, and then 6 monthly cycles of Temodar chemotherapy. The studies defining this Standard of Care achieved a median time to progression of 6.9 months and a median overall survival of 14.6 months (Stupp, et. al., N Engl J Med, 352:987, 2005). Further data from UCLA have demonstrated a somewhat longer median time to progression of 8.1 months and median overall survival of 17.0 months in patients with GBM who received Standard of Care.

The year-end 2007 data obtained by the Company concerning the 19 patients from the two trials at UCLA with newly diagnosed GBM continue to be positive, with no patients progressing and onl
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 2015  Agena Bioscience today announced Bioyong Technology as the ... in China . "The Chinese ... hotbed for practical, meaningful innovations that are improving human health ... rest of the world. We are proud to support the ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
(Date:4/27/2015)... 27, 2015 China Jo-Jo Drugstores, ... Jo-Jo "), a leading China-based retail and wholesale distributor ... online and retail pharmacies, today announced its subsidiary, Hangzhou ... signed a new sales incentive agreement with Wyeth Pharmaceutical ... China of Pfizer Inc. (NYSE: ...
(Date:4/27/2015)... , April 27, 2015 TWi Pharmaceuticals, ... into a Settlement Agreement with Takeda Pharmaceutical Company ... Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, ... litigation related to TWi,s generic dexlansoprazole delayed release ... 60 mg dosage strengths. An Abbreviated New Drug Application ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2
... a premier provider of economic ultrasound solutions, today announced ... on proprietary repair technology not previously available in the ... transducer repair services designed to counter a growing emphasis ... "The industry has been moving away from repairing customers, ...
... Technologies, Inc. (OTC Bulletin Board: WNDM ) ... (WCI), has entered into a partnership with Government Marketing ... further WCI,s business development within the Veterans Health Administration. ... leader by technology and industry manufacturers as ...
Cached Medicine Technology:MedPro Imaging Launches Ultrasound Transducer Repair Division 2Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration 2Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration 3Wound Management Technologies, Inc. Furthers its Government Initiatives and Business Development within the Veterans Health Administration 4
(Date:4/27/2015)... 2015 Pure n Natural Systems, Inc. ... new website design at http://www.purennatural.com/ . The ... product catalog, both featured and sale items, as well ... ). , Pure n Natural Systems’ website is designed ... The website is neatly organized and provides plenty of ...
(Date:4/27/2015)... Ore. (PRWEB) April 27, 2015 ... Ben Albert has joined its team as Operating ... an area focused on investing in and building companies ... system. In his new role, Albert will be responsible ... health care so that it is both economically sustainable ...
(Date:4/27/2015)... Livermore, CA (PRWEB) April 27, 2015 ... services, is expanding its Texas operations with the addition ... better provide life safety services to a growing customer ... the team as a new Senior Account Manager. Curtis ... business and support existing customers throughout the Houston area ...
(Date:4/27/2015)... Alabama (PRWEB) April 27, 2015 Health ... soon have a first-of-its-kind bakery right on their doorstep, ... especially for those on restrictive and low-carbohydrate diets. ... gluten, grain, and starch free, and will use only ... opening May 1, 2015, strives to provide specialty food ...
(Date:4/27/2015)... Jvion, the Atlanta-based leader in clinical predictive algorithms, ... one of the top 40 fastest growing companies in ... the Atlanta Business Chronicle, honors Atlanta’s fastest-growing privately held ... economic capital and employment hub. , Shantanu Nigam, Jvion’s ... growing need to improve healthcare quality while reducing costs. ...
Breaking Medicine News(10 mins):Health News:Pure n Natural Systems, Inc. Launches New Website Design 2Health News:Pure n Natural Systems, Inc. Launches New Website Design 3Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2
... Sept. 14 Novavax Inc.,(Nasdaq: NVAX ) today ... will present a corporate overview and highlight recent,developments at ... 24, 2007 at 9:30 a.m. Eastern Time at the ... to Dr. Singhvi,s live web cast of Novavax,s presentation ...
... Air traffic controllers,from the Detroit Metro Air Traffic ... (Mich.) Circuit Court regarding a nearly three-year-old,problem of ... including,several who have missed significant amounts of work ... problems. The suit contains allegations that contractors ...
... Plus Increased ... Coverage ,On Demand, DALLAS, Sept. ... promising affordable individual health insurance for the,estimated three million uninsured young, ... Precedent | Remix(TM) individual health,insurance products at http://www.precedent.com, the ...
... for tackling heart disease are too complex. They should ... prevention and less on risk factor measurement, experts advise ... the United Kingdom has the largest healthcare pay for ... outcomes framework (QOF). Practices earn points for the services ...
... Texas Medical Branch at Galveston are trying to determine ... also be used to delay delivery in expectant mothers ... give hope to hundreds of thousands of women who ... Digibind, has been prescribed for over 20 years to ...
... One of the Largest PPO Dental Networks in The United ... Dependents ... Area, NEW YORK, Sept. 14 The Guardian Life ... voluntary,benefits for small and midsize business, today announced that its ...
Cached Medicine News:Health News:Detroit Metro Tower Air Traffic Controllers File Lawsuit Alleging Improper Mold Removal and Health Effects 2Health News:Precedent Launches Revolutionary Individual Health Insurance Plans in Texas 2Health News:Precedent Launches Revolutionary Individual Health Insurance Plans in Texas 3Health News:GP targets on heart disease should be simpler and based more on treatment and prevention 2Health News:Guardian's Dental Network Experiences Double-Digit Growth 2Health News:Guardian's Dental Network Experiences Double-Digit Growth 3
... system capable of handling a multitude of ... of the tests allows you to tailor ... staffs' needs. Any tests not included in ... easily be handled using the Doppler, PVR ...
... Nicolet VersaLab is a ... Doppler system for evaluation ... Crisp, clear Doppler sound ... a display and print-out ...
Silhouette is easy to use with uncompromised biomechanics and is the most refined posterior fixation system....
The CD Horizon Legacy Spinal System is part of the CD Horizon Spinal System designed for use in small stature patients. The posterior implants (hook and screws) are designed to fit patients in the ra...
Medicine Products: